| 000 | 02693nam a22003377a 4500 | ||
|---|---|---|---|
| 003 | OSt | ||
| 005 | 20240305192609.0 | ||
| 008 | 220831b |||||||| |||| 00| 0 eng d | ||
| 020 | _a1405181427 | ||
| 020 | _a9781405181426 | ||
| 040 | _cDLC | ||
| 050 | _aRC281.C4E95 2007 | ||
| 050 | _a QZ 275 E93 2007 | ||
| 082 |
_a22 _2618.92'994 PIN |
||
| 100 |
_aRoss Pinkerton _943736 |
||
| 222 | _a6-mercaptopurine actinomycin acute lymphoblastic leukemia acute myeloid leukemia American Society analysis ARA-C asparaginase bone marrow cell chemotherapy childhood acute Children’s Cancer Group cisplatin Clin Oncol Clinical Oncology full CNS prophylaxis compared complete remission consolidation cranial irradiation cycles cyclophosphamide cytarabine daunorubicin Details dexamethasone diagnosis disease domized doxorubicin duration eligible patients etoposide evaluate Ewing’s excluded Figure GCSF GCSF group given GMCSF groups of patients high dose high risk ifosfamide included induction therapy infusion intravenous lymphoma maintenance therapy median medulloblastoma metastases methotrexate mg/m2 days neutropenia number of patients Objectives The aim Oncology full reference oral Outcome measures overall survival patients randomized patients received patients were randomized pegaspargase phase platelet prednisolone prednisone protocol radiation radiotherapy randomized to receive regimen risk group sarcoma Society of Clinical stage Study design surgery Table thioguanine toxicity transfusions treated treatment tumor versus vincristine weeks | ||
| 245 |
_aEvidence-Based Pediatric Oncology _bEvidence-Based Medicine |
||
| 250 | _a2nd edition | ||
| 260 |
_aOxford: _bJohn Wiley & Sons, _cc2008 |
||
| 300 | _a576 pages | ||
| 520 | _aUsing the available systematic reviews and Standard OptionsRecommendations (SORs) which are evidence-based treatmentrecommendations, Evidence-based Pediatric Oncology is aground breaking text on the management of childhood cancers.Covering all tumour types occuring in children and young adults, itprovides systematic reviews with recommendations for optimumtreatments for childhood cancer. Offering reviews and commentaries from leading internationallyrecognised paediatric oncologists, this fully revised secondedition now covers significant randomised controlled trails. | ||
| 600 |
_xNeoplasms. _927978 |
||
| 600 |
_x Child. _928179 |
||
| 600 |
_xEvidence-Based Medicine. _928141 |
||
| 600 |
_xMedical / Oncology / General _926891 |
||
| 600 |
_x Medical / General _926821 |
||
| 600 |
_x Medical › Oncology › General _926780 |
||
| 700 |
_aA. G. Shankar _943737 |
||
| 700 |
_aKatherine Matthay _943738 |
||
| 942 |
_2ddc _cBK |
||
| 999 |
_c9187 _d9187 |
||